Ryan Crandall - 29 Nov 2025 Form 4 Insider Report for MARIMED INC. (MRMD)

Role
Chief Commercial Officer
Signature
/s/ Ryan Crandall
Issuer symbol
MRMD
Transactions as of
29 Nov 2025
Net transactions value
-$1,972
Form type
4
Filing time
02 Dec 2025, 16:07:36 UTC
Previous filing
29 Sep 2025
Next filing
08 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Crandall Ryan Chief Commercial Officer 10 OCEANA WAY, 2ND FLOOR, NORWOOD /s/ Ryan Crandall 02 Dec 2025 0002062820

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRMD Common stock Options Exercise $0 +75,000 +10% $0.000000 806,938 29 Nov 2025 Direct F1
transaction MRMD Common stock Tax liability $1,972 -22,013 -2.7% $0.0896 784,925 29 Nov 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRMD Restricted Stock Units (RSU) Options Exercise $0 -75,000 -33% $0.000000 150,000 29 Nov 2025 Common Stock, par value $.001 per share 75,000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSUs convert to shares of common stock on a one-for-one basis.
F2 Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
F3 These RSUs were granted on November 29, 2024; the remaining RSUs under this grant will vest in four equal installments, on each of May 29, 2026, November 29, 2026, May 29, 2027 and November 29, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.